{"id":162644,"date":"2022-06-28T01:47:38","date_gmt":"2022-06-28T05:47:38","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/mountain-valley-md-successfully-completes-pre-clinical-pharmacokinetic-study-for-soluvec1\/"},"modified":"2024-08-18T11:44:39","modified_gmt":"2024-08-18T15:44:39","slug":"mountain-valley-md-successfully-completes-pre-clinical-pharmacokinetic-study-for-soluvec1","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/mountain-valley-md-successfully-completes-pre-clinical-pharmacokinetic-study-for-soluvec1.php","title":{"rendered":"Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec\u21221%"},"content":{"rendered":"<p><![CDATA[TORONTO, June  27, 2022  (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the \u201cCompany\u201d or \u201cMVMD\u201d) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce the successful completion of its pre-clinical pharmacokinetic study - IM032 - in male beagle dogs comparing intramuscular (\u201cIM\u201d) and subcutaneous (\u201cSC\u201d) dosing of Soluvec\u2122 1% with oral administration of commercially available branded ivermectin.]]><\/p>\n<p>See the original post here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/27\/2469588\/0\/en\/Mountain-Valley-MD-Successfully-Completes-Pre-Clinical-Pharmacokinetic-Study-For-Soluvec-1.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec\u21221%\">Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec\u21221%<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post here: Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec\u21221% <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/mountain-valley-md-successfully-completes-pre-clinical-pharmacokinetic-study-for-soluvec1.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162644","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162644"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162644"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162644\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}